Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Research about potential prevention strategies, including the use of semaglutide, a drug used to treat type 2 diabetes and aid weight loss, is ongoing. Results of a secondary analysis found that ...

This research holds promise for helping people with MASH and suggests another potential benefit of semaglutide. Ian Storch, DO, an osteopathic physician specializing in gastroenterology and ...